Three Seasons Wealth LLC acquired a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 1,874 shares of the medical instruments supplier's stock, valued at approximately $291,000.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. Arizona State Retirement System boosted its position in shares of ICU Medical by 1.0% during the fourth quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock worth $1,044,000 after buying an additional 65 shares during the period. Huntington National Bank raised its holdings in ICU Medical by 6.2% during the fourth quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier's stock worth $218,000 after purchasing an additional 82 shares in the last quarter. Equitable Trust Co. raised its holdings in ICU Medical by 1.6% during the fourth quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock worth $822,000 after purchasing an additional 84 shares in the last quarter. LPL Financial LLC raised its holdings in ICU Medical by 2.0% during the fourth quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier's stock worth $747,000 after purchasing an additional 93 shares in the last quarter. Finally, Alliancebernstein L.P. raised its holdings in ICU Medical by 0.5% during the fourth quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier's stock worth $4,051,000 after purchasing an additional 136 shares in the last quarter. 96.10% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
ICUI has been the topic of several research reports. KeyCorp dropped their price target on ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. StockNews.com cut shares of ICU Medical from a "buy" rating to a "hold" rating in a research report on Thursday. Finally, Raymond James set a $97.00 price objective on shares of ICU Medical in a research report on Wednesday, March 12th. Two equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, ICU Medical presently has an average rating of "Moderate Buy" and a consensus target price of $162.67.
Check Out Our Latest Report on ICU Medical
ICU Medical Trading Up 0.2 %
NASDAQ ICUI traded up $0.24 on Monday, hitting $135.90. 297,693 shares of the stock were exchanged, compared to its average volume of 274,101. ICU Medical, Inc. has a 52-week low of $95.44 and a 52-week high of $196.26. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The company has a market capitalization of $3.34 billion, a price-to-earnings ratio of -29.74 and a beta of 0.86. The company's 50-day moving average price is $143.25 and its two-hundred day moving average price is $157.64.
ICU Medical Company Profile
(
Free Report)
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.
Featured Stories

Before you consider ICU Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.
While ICU Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.